Oculis Holding AG announced the appointment of global commercial executive with extensive ophthalmology experience, Rebecca Weil, to the role of Chief Commercial Officer. In this key role, Ms. Weil will lead the organization to commercial readiness from designing launch strategies for U.S. and globally, and building the required commercial infrastructure to bring all of Oculis? groundbreaking ophthalmic product candidates to markets worldwide.

Ms. Weil is a seasoned commercial executive with 20 years of experience in biotech and large pharmaceutical companies at the global, regional, and local levels. Prior to joining Oculis, she was the Senior Vice President, Head of Global Marketing for Idorsia where she built the team, defined the go-to-market strategies and launched the company?s first two products. Ms. Weil started her career in strategic consulting at McKinsey & Company, and held commercial leadership positions at Novartis, Bausch + Lomb, Alcon and Shire where she led the global ophthalmology and neuroscience franchises and product launch strategy development. She received her Ph.D. in political science from Massachusetts Institute of Technology (MIT) and holds a B.A. in public and international affairs from Princeton University.